These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2516368)

  • 1. TPA versus urokinase in acute pulmonary embolism: results of a randomized controlled trial.
    Goldhaber SZ
    Vasa Suppl; 1989; 27():292-4. PubMed ID: 2516368
    [No Abstract]   [Full Text] [Related]  

  • 2. Urokinase versus tissue plasminogen activator in pulmonary embolism.
    Lancet; 1988 Sep; 2(8612):691-2. PubMed ID: 2901554
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
    Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
    Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low dosage fibrinolytic therapy with r-TPA in thromboses of the deep venous system].
    Hagg NB
    Vasa Suppl; 1991; 33():124-5. PubMed ID: 1788640
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tissue plasminogen activator after resuscitation in fulminant pulmonary embolism].
    Böttiger BW
    Dtsch Med Wochenschr; 1995 Nov; 120(44):1528-9. PubMed ID: 7588025
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?
    Dalen JE; Alpert JS; Hirsh J
    Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222
    [No Abstract]   [Full Text] [Related]  

  • 7. [Short-term thrombolytic therapy in pulmonary artery embolism with rt-PA].
    Stark G; Pilger E; Smolle H; Sterz F; Decrinis M; Obernosterer A; Aschauer M; Flückiger F; Lafer M; Pieber D
    Vasa Suppl; 1991; 33():126. PubMed ID: 1788641
    [No Abstract]   [Full Text] [Related]  

  • 8. Modern treatment of pulmonary embolism.
    Kessler CM
    Lung; 1990; 168 Suppl():841-8. PubMed ID: 2117202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic fibrinolysis with recombinant tissue-type plasminogen activator in subrenal aortic occlusions].
    Hönigl K; Pilger E; Stark G; Bertuch H
    Vasa Suppl; 1988; 26():99-102. PubMed ID: 3144050
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
    Idell S; Azghani A; Chen S; Koenig K; Mazar A; Kodandapani L; Bdeir K; Cines D; Kulikovskaya I; Allen T
    Exp Lung Res; 2007; 33(8-9):419-40. PubMed ID: 17994370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical treatment of pulmonary thromboembolism].
    Nagata H; Kawakami Y
    Kokyu To Junkan; 1989 Sep; 37(9):961-5. PubMed ID: 2512601
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuroendovascular therapy for acute stroke].
    Ezura M; Takahashi A; Matsumoto Y
    No To Shinkei; 2006 Nov; 58(11):937-43. PubMed ID: 17133999
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study on the effects of low dose of tPA and different regimens of intravenous urokinase in acute myocardial infarction.
    Shen W; Zhang R; Zhang J; Zhang D; Zhang X; Zheng A
    Chin Med J (Engl); 1999 Jan; 112(1):18-21. PubMed ID: 11593632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of acute and chronic pulmonary thromboembolism].
    Hiraoka N; Fujioka H; Nakano T
    Kokyu To Junkan; 1993 Sep; 41(9):829-33. PubMed ID: 8210740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bolus injection of recombinant tissue-type plasminogen activator during cardiopulmonary resuscitation in massive pulmonary embolism complicated with heart arrest. Report of 2 cases and review of the literature].
    Moretti C; De Felice F; Mazza A; Pinneri F
    Ital Heart J Suppl; 2003 May; 4(5):420-3. PubMed ID: 12848080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
    Wu JH; Diamond SL
    J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute pulmonary embolism].
    Meissner E; Niedermeyer J; Fabel H
    Z Kardiol; 1993; 82 Suppl 2():3-12. PubMed ID: 8328207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled clinical trial on the effect of heparin infusion and two regimens of urokinase in acute pulmonary embolism.
    Giuntini C; Marini C; Di Ricco G; Palla R; Giacomelli V; Rindi M
    G Ital Cardiol; 1984; 14 Suppl 1():26-9. PubMed ID: 6398781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can systemic changes in the blood coagulation system be detected in low-dose local thrombolysis with r-tPA?].
    Weichenhain B; Stiegler H; Spengel F; Standl E; Woitinas F; Roth R; Schulz K; Mehnert H
    Vasa Suppl; 1991; 32():314-7. PubMed ID: 1771523
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolysis in the treatment of submassive pulmonary embolism.
    Mascitelli L; Pezzetta F
    Arch Intern Med; 2003 May; 163(10):1238; author reply 1238. PubMed ID: 12767964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.